HOME > BUSINESS
BUSINESS
- MTPC Aims to Reach Midterm Targets through Royalties from Licensed Products, But Success Likely to Depend on Performance in Domestic Market
November 8, 2013
- Japan ARB Market Gets Back on Growth Track in April-September; No Major Impact from Diovan Woes
November 6, 2013
- Safety Profile Holds Key to Triumph of Edoxaban: Daiichi Sankyo President
November 6, 2013
- Daiichi Sankyo President Apologizes Over Ranbaxy Problem, Pledges to Resolve Issue by Dispatching Employees
November 6, 2013
- Takeda to Cut Costs by 100 Billion Yen, Reduce Workforce by Below 5%
November 5, 2013
- Growth-Engine Drugs Jack Up Eisai Sales in April-September; Aricept’s Japan Target within Sight
November 5, 2013
- Astellas Plans to Tap 300 Workers in Japan for Early Retirement in FY2014
November 5, 2013
- Astellas 1st Half Operating Profit Down 4.4% on Higher Sales
November 5, 2013
- Shionogi Logs Record Profits in April-September on Rigid Cost Control
November 1, 2013
- Daiichi Sankyo Sales Up 7% Thanks to Nexium, Ranbaxy Posts Net Loss
November 1, 2013
- Takeda 1st Half Sales Rise 5.3% on New Portfolio, Weaker Yen
November 1, 2013
- MTPC Sales of Domestic Ethical Drugs Down 3.2% in April-September Period Due to Generic Competition
October 31, 2013
- DSP North America Sales Up 11.8% Due to Latuda, Japan Sales Down 4.2% in April-September Period
October 31, 2013
- Stock-Out of Mucosolate, Lemalc Due to Non-Conformance Results of Dissolution Testing, Stable Supply to Resume Next Spring: Teva Pharma Japan
October 31, 2013
- Teva Pharma Japan Notifies Customers of Stock-Out of Mucosolate L Cap.45, Lemalc Tab. 100 Due to Manufacturing Troubles
October 30, 2013
- Taiwan Approval Sought for DSP’s Antipsychotic Lurasidone
October 30, 2013
- Eli Lilly Italy Pres. Jönsson to Take Reins of Japan Operations
October 29, 2013
- Teva’s Global Medical Director Says Biosimilars Can Cut Medical Costs
October 25, 2013
- Tamiflu Supply Plan for This Season Down by 3 Million Treatment Courses against Last Season: Chugai
October 25, 2013
- Race for Top Brands for BPH Tightens as Generics Make Inroads; OAB Market Grows as Disease Entity Becomes Better Defined
October 25, 2013
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…